Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /EPiServer/CMS/ Disallow: |
Title | Home | VYZULTA® (latanoprostene bunod ophthalmic solution), |
Description | IOP REDUCTION VYZULTA® is a once-nightly eye drop for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Please see full Prescribing |
Keywords | Vyzulta HCP |
WebSite | vyzultahcp.com |
Host IP | 45.60.73.143 |
Location | United States |
Site | Rank |
US$10,516,274
Last updated: 2023-05-12 12:42:06
vyzultahcp.com has Semrush global rank of 1,006,469. vyzultahcp.com has an estimated worth of US$ 10,516,274, based on its estimated Ads revenue. vyzultahcp.com receives approximately 1,213,417 unique visitors each day. Its web server is located in United States, with IP address 45.60.73.143. According to SiteAdvisor, vyzultahcp.com is safe to visit. |
Purchase/Sale Value | US$10,516,274 |
Daily Ads Revenue | US$9,708 |
Monthly Ads Revenue | US$291,220 |
Yearly Ads Revenue | US$3,494,639 |
Daily Unique Visitors | 80,895 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
vyzultahcp.com. | A | 3600 | IP: 45.60.73.143 |
vyzultahcp.com. | A | 3600 | IP: 45.60.109.143 |
vyzultahcp.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
vyzultahcp.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
vyzultahcp.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
vyzultahcp.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
vyzultahcp.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
vyzultahcp.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
vyzultahcp.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
vyzultahcp.com. | TXT | 3600 | TXT Record: 199F-CC41-F2C9-29F8-7AD4-028C-C386-9EF1 |
SAMPLES IMPORTANT SAFETY INFORMATION PRESCRIBING INFORMATION PHARMACIST SITE PATIENT SITE SIGN UP Sign Up EFFICACY & SAFETY MECHANISM OF ACTION SAVINGS, ACCESS, & DOSING RESOURCE LIBRARY Samples Important Safety Information Prescribing Information Pharmacist Site Patient Site Sign Up EFFICACY & SAFETY MECHANISM OF ACTION SAVINGS, ACCESS, & DOSING RESOURCE LIBRARY IOP REDUCTION WITH MORE HORSEPOWER Significantly greater intraocular pressure (IOP) reduction vs timolol 0.5% or Xalatan (latanoprost) 0.005% in clinical trials 1-4 POWERFUL IOP REDUCTION WITH EXCELLENT TOLERABILITY 1,5 experienced conjunctival hyperemia in Phase 3 trials 1,5 due to any ocular adverse event 1 EXPLORE THE DATA UNIQUE DELIVERY OF NITRIC OXIDE WITH LATANOPROST ACID Nitric oxide improves permeability of the primary outflow pathway through trabecular relaxation. 1,6-8 WATCH IT WORK WATCH AS DR. SINGH SHARES HIS THOUGHTS ON WHAT MAKES THE VYZULTA DUAL MECHANISM OF ACTION UNIQUE UTILIZE TOOLS AND RESOURCES FOR |
HTTP/1.1 301 Moved Permanently Location: https://www.vyzultahcp.com/ Content-Length: 0 Connection: close HTTP/2 200 cache-control: public content-length: 34253 content-type: text/html; charset=utf-8 set-cookie: dnn_IsMobile=False; path=/; HttpOnly set-cookie: language=en-US; path=/; HttpOnly set-cookie: .ASPXANONYMOUS=nmNKVnEkx6VmJd_ZapVAZQ9RLn3LjQLsYY8LqTHhpDKykeea9V56NGs4ZnAbl0Nj_Bh1h2e7dL70Sufv4T5Dl7NeEFdFIu4EfkQ5sQw_I_UGyUDy0; expires=Thu, 24-Feb-2022 19:22:40 GMT; path=/; HttpOnly set-cookie: Analytics_VisitorId=3d322184-66fb-4f08-9f4d-0fc2d72a6e54; expires=Sun, 16-Jan-2022 08:42:40 GMT; path=/; HttpOnly set-cookie: Analytics=SessionId=caf2e2c6-bc94-40f4-8462-45e3bb65743d&TabId=22066&ContentItemId=-1; expires=Fri, 17-Dec-2021 09:42:40 GMT; path=/; HttpOnly x-ua-compatible: IE=edge set-cookie: dnn_IsMobile=False; path=/; HttpOnly set-cookie: language=en-US; path=/; HttpOnly set-cookie: .ASPXANONYMOUS=nmNKVnEkx6VmJd_ZapVAZQ9RLn3LjQLsYY8LqTHhpDKykeea9V56NGs4ZnAbl0Nj_Bh1h2e7dL70Sufv4T5Dl7NeEFdFIu4EfkQ5sQw_I_UGyUDy0; expires=Thu, 24-Feb-2022 19:22:40 GMT; path=/; HttpOnly set-cookie: Analytics_VisitorId=3d322184-66fb-4f08-9f4d-0fc2d72a6e54; expires=Sun, 16-Jan-2022 08:42:40 GMT; path=/; HttpOnly set-cookie: Analytics=SessionId=caf2e2c6-bc94-40f4-8462-45e3bb65743d&TabId=22066&ContentItemId=-1; expires=Fri, 17-Dec-2021 09:42:40 GMT; path=/; HttpOnly set-cookie: __RequestVerificationToken=F2gfx6upRjengyGU0eCdwIw9aQ0sUHZ7ikT3POrQN94XVdsEkJZv8KfxbqAGsuJLZA3xDQ2; path=/; HttpOnly x-xss-protection: 1; mode=block x-frame-options: SAMEORIGIN date: Fri, 17 Dec 2021 08:42:39 GMT set-cookie: visid_incap_2660441=hmuwRzY6RwuQwae50dt4g35NvGEAAAAAQUIPAAAAAAA5/tMP+LSWdC6q1WOfS2Gr; expires=Sat, 17 Dec 2022 07:06:21 GMT; HttpOnly; path=/; Domain=.vyzultahcp.com set-cookie: nlbi_2660441=GHuDOIUcYTqiswo4fshdqwAAAADqYb+4F9FWITVj50MLl2tm; path=/; Domain=.vyzultahcp.com set-cookie: incap_ses_702_2660441=Rd+XSmZ/iiXjzQzc4wG+CX9NvGEAAAAANNbKMPFO34giyrloWIMoLA==; path=/; Domain=.vyzultahcp.com x-cdn: Imperva x-iinfo: 14-48118499-48118500 NNNN CT(9 342 0) RT(1639730558836 0) q(0 0 3 0) r(4 4) U6 |
Domain Name: VYZULTAHCP.COM Registry Domain ID: 2165598727_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-08-20T09:36:29Z Creation Date: 2017-09-21T16:01:02Z Registry Expiry Date: 2023-09-21T16:01:02Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-17T07:28:17Z <<< |